68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Status:
Recruiting
Trial end date:
2024-07-21
Target enrollment:
Participant gender:
Summary
This early phase I trial studies an imaging technique called 68Ga-FAPi-46 PET/CT to determine
where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulates in normal and cancer
tissues in patients with sarcoma. PET is an established imaging technique that utilizes small
amounts of radioactivity attached to very minimal amounts of tracer, in the case of this
research, 68Ga-FAPi. Because some cancers take up 68Ga-FAPi it can be seen with PET. CT
utilizes x-rays that traverse body from the outside. CT images provide an exact outline of
organs and potential inflammatory tissue where it occurs in patient's body.